Sixty million pounds dedicated to diabetes breakthrough science
£60M+
active portfolio
42
university labs
18
clinical trials
Rigorous peer-reviewed investigations targeting automated delivery, metabolic remission, and long-term organ protection.
Automated Insulin Delivery
Remission Science
Vascular Protection
Evaluating next-generation closed-loop systems and predictive algorithm safety across diverse patient cohorts in NHS clinical settings.
Long-term follow-up studies examining weight management interventions and sustained beta-cell function recovery mechanisms.
Targeting early microvascular preservation and novel therapeutic pathways to prevent long-term diabetes-related complications.


Documentary photograph of clinical researchers analyzing trial outcomes alongside patient advocates at a UK university facility.
Open-access trial reports and patient summaries
Download vetted reference documents, school healthcare plans, and investigator summaries for clinical practice.
